ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice

The Middle East respiratory syndrome coronavirus (MERS-CoV) has infected more than 1900 humans, since 2012. The syndrome ranges from asymptomatic and mild cases to severe pneumonia and death. The virus is believed to be circulating in dromedary camels without notable symptoms since the 1980s. Theref...

Descripción completa

Detalles Bibliográficos
Autores principales: Alharbi, Naif Khalaf, Padron-Regalado, Eriko, Thompson, Craig P., Kupke, Alexandra, Wells, Daniel, Sloan, Megan A., Grehan, Keith, Temperton, Nigel, Lambe, Teresa, Warimwe, George, Becker, Stephan, Hill, Adrian V.S., Gilbert, Sarah C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516308/
https://www.ncbi.nlm.nih.gov/pubmed/28579232
http://dx.doi.org/10.1016/j.vaccine.2017.05.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516308/
https://www.ncbi.nlm.nih.gov/pubmed/28579232
http://dx.doi.org/10.1016/j.vaccine.2017.05.032

Ejemplares similares